Ultragenyx Pharmaceutical Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $1.50B
Liabilities Breakdown FY2024
Total Liabilities: $1.24B
Asset Breakdown
Total Assets: $1.50B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $174.0M | 11.6% |
| Accounts Receivable | $122.0M | 8.1% |
| Inventory | $45.0M | 3.0% |
| Property, Plant & Equipment | $266.0M | 17.7% |
| Goodwill | $44.0M | 2.9% |
| Intangible Assets | $178.0M | 11.8% |
| Other Assets | $674.0M | 44.8% |
Liabilities Breakdown
Total Liabilities: $1.24B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $39.0M | 3.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.20B | 96.9% |